Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein

Article de synthese traitant de la pharmacologie de l'oxyde nitrique, du facteur EDRF et du GMP cyclique dans les vaisseaux sanguins et les thrombocytes, de l'isolation et de l'identification du facteur EDRF comme de l'oxyde nitrique, et de la formation, de la liberation et du metabolisme de l'endothelium derived NO (EDNO)

[1]  D. R. McCalla,et al.  Reactions of cysteine with N-methyl-N-nitroso-p-toluenesulfonamide and N-methyl-N′-nitro-N-nitrosoguanidine , 1969 .

[2]  M. Marletta,et al.  Synthesis of nitrite and nitrate in murine macrophage cell lines. , 1987, Cancer research.

[3]  F. Murad,et al.  Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase , 1975, Nature.

[4]  R. Miller,et al.  Endothelial mediated inhibition of contraction and increase in cyclic GMP levels evoked by the α‐adrenoceptor agonist B‐HT 920 in rat isolated aorta , 1984, British journal of pharmacology.

[5]  M. Lewis,et al.  The nature of endothelium-derived vascular relaxant factor , 1984, Nature.

[6]  P. Vanhoutte,et al.  Flow-induced release of endothelium-derived relaxing factor. , 1986, The American journal of physiology.

[7]  M. Peach,et al.  Endothelium-dependent relaxation of rabbit aorta. II. Inhibition of relaxation stimulated by methacholine and A23187 with antagonists of arachidonic acid metabolism. , 1983, The Journal of pharmacology and experimental therapeutics.

[8]  H. Karaki,et al.  Role of endothelium in the contractions induced by norepinephrine and clonidine in rat aorta. , 1985, Japanese journal of pharmacology.

[9]  M. Haddox,et al.  Redox modulation of splenic cell soluble guanylate cyclase activity: activation by hydrophilic and hydrophobic oxidants represented by ascorbic and dehydroascorbic acids, fatty acid hydroperoxides, and prostaglandin endoperoxides. , 1978, Advances in cyclic nucleotide research.

[10]  J. Vane,et al.  Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  F. DeRubertis,et al.  Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation. , 1978, The Journal of biological chemistry.

[12]  H. Sparks,et al.  Mediation of flow-dependent arterial dilation by endothelial cells. , 1986, Circulatory shock.

[13]  K. Kuriyama,et al.  Activation of cerebral guanylate cyclase by nitric oxide. , 1977, Biochemical and biophysical research communications.

[14]  P. Vanhoutte,et al.  Bioassay of endothelium-derived relaxing factor(s): inactivation by catecholamines. , 1985, The American journal of physiology.

[15]  M. Lewis,et al.  Evidence that inhibitory factor extracted from bovine retractor penis is nitrite, whose acid‐activated derivative is stabilized nitric oxide , 1988, British journal of pharmacology.

[16]  M. Marletta,et al.  Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. , 1987, Journal of immunology.

[17]  Richard E. White,et al.  α1- and α2-adrenoceptor agonist-induced contraction in rat mesenteric artery upon removal of endothelium , 1986 .

[18]  S. Moncada,et al.  ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM , 1987, The Lancet.

[19]  R. Furchgott,et al.  Endothelial cells as mediators of vasodilation of arteries. , 1984, Journal of cardiovascular pharmacology.

[20]  D. Ku,et al.  Magnesium deficiency produces endothelium-dependent vasorelaxation in canine coronary arteries. , 1987, The Journal of pharmacology and experimental therapeutics.

[21]  P. Vanhoutte,et al.  Potassium-free solution prevents the action but not the release of endothelium-derived relaxing factor. , 1988, European Journal of Pharmacology.

[22]  T. Stone,et al.  The release of endothelium-derived relaxant factor is calcium dependent. , 1985, Blood vessels.

[23]  F. Murad,et al.  Activation of guanylate cyclase from rat liver and other tissues by sodium azide. , 1975, The Journal of biological chemistry.

[24]  R. Haslam.  Roles of cyclic nucleotides in platelet function. , 1975, Ciba Foundation symposium.

[25]  B. Altura,et al.  Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle. , 1978, European journal of pharmacology.

[26]  P. Vanhoutte,et al.  Anoxia and endothelium‐dependent reactivity of the canine femoral artery. , 1983, The Journal of physiology.

[27]  S. Moncada,et al.  Comparative pharmacology of EDRF and nitric oxide on vascular strips. , 1987, European journal of pharmacology.

[28]  R. Haslam,et al.  Regulation of blood platelet function by cyclic nucleotides. , 1978, Advances in cyclic nucleotide research.

[29]  K. Shine.  Myocardial effects of magnesium. , 1979, The American journal of physiology.

[30]  G. Schultz,et al.  Soluble guanylate cyclase purified from bovine lung contains heme and copper , 1981, FEBS letters.

[31]  S. Vatner,et al.  Reactive Dilation of Large Coronary Arteries in Conscious Dogs , 1984, Circulation research.

[32]  J. Wikberg,et al.  Vascular smooth muscle relaxation by nitro compounds: reduced relaxation and cGMP elevation in tolerant vessels and reversal of tolerance by dithiothreitol. , 2009, Acta pharmacologica et toxicologica.

[33]  R. Busse,et al.  Stimulation of Soluble Guanylate Cyclase by an Acetylcholine‐Induced Endothelium‐Derived Factor from Rabbit and Canine Arteries , 1986, Circulation research.

[34]  L. Ignarro,et al.  Vasodilator actions of several N-nitroso compounds. , 1982, Canadian journal of physiology and pharmacology.

[35]  A. Thomson,et al.  Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. , 1987, Circulation research.

[36]  M. Peach,et al.  Endothelium‐Derived Vascular Relaxing Factor , 1985, Hypertension.

[37]  M. Wolin,et al.  Hydrogen peroxide elicits activation of bovine pulmonary arterial soluble guanylate cyclase by a mechanism associated with its metabolism by catalase. , 1987, Biochemical and biophysical research communications.

[38]  L. Wexler,et al.  The Effects of Ergonovine Maleate on Coronary Arterial Size , 1979, Circulation.

[39]  D. Waters,et al.  Comparative Sensitivity of Exercise, Cold Pressor and Ergonovine Testing in Provoking Attacks of Variant Angina in Patients with Active Disease , 1982, Circulation.

[40]  L. Ignarro,et al.  Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. , 1979, Journal of cyclic nucleotide research.

[41]  H. Schröder,et al.  Evidence for a correlation between nitric oxide formation by cleavage of organic nitrates and activation of guanylate cyclase. , 1985, Journal of molecular and cellular cardiology.

[42]  R. Busse,et al.  Species-dependent differences in the nature of endothelium-derived vascular relaxing factor. , 1984, European journal of pharmacology.

[43]  A. Chait,et al.  Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. , 1986, The Journal of clinical investigation.

[44]  C. A. Gruetter,et al.  Bradykinin-induced endothelium-dependent relaxation of bovine intrapulmonary artery and vein. , 1986, European journal of pharmacology.

[45]  C. Kappagoda,et al.  Endothelium-dependent relaxation and experimental atherosclerosis in the rabbit aorta. , 1986, Canadian journal of physiology and pharmacology.

[46]  L. Ignarro,et al.  Guanylate cyclase from bovine lung. Evidence that enzyme activation by phenylhydrazine is mediated by iron-phenyl hemoprotein complexes. , 1984, The Journal of biological chemistry.

[47]  F. Murad,et al.  Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Peach,et al.  Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta. , 1982 .

[49]  P. Vanhoutte,et al.  Interaction between Na+,K+ exchanges and the direct inhibitory effect of acetylcholine on canine femoral arteries. , 1980, Circulation research.

[50]  B. Freeman,et al.  Detection of superoxide generated by endothelial cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[51]  U. Förstermann,et al.  Mechanisms of action of lipoxygenase and cytochrome P‐450‐mono‐oxygenase inhibitors in blocking endothelium‐dependent vasodilatation , 1988, British journal of pharmacology.

[52]  L. Ignarro,et al.  Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle. , 1988, The Journal of pharmacology and experimental therapeutics.

[53]  J. Wikberg,et al.  Relationship between nitroglycerin, cyclic GMP and relaxation of vascular smooth muscle. , 1979, Life sciences.

[54]  S. Gottlieb,et al.  Prevention and reversal of nitrate tolerance in patients with congestive heart failure. , 1987, The New England journal of medicine.

[55]  W. Halpern,et al.  Effects of perfusion and endothelium on the reactivity of isolated resistance arteries. , 1985, Blood vessels.

[56]  P. D. Lawley,et al.  Methylation of deoxyribonucleic acid in cultured mammalian cells by N-methyl-N'-nitro-N-nitrosoguanidine. The influence of cellular thiol concentrations on the extent of methylation and the 6-oxygen atom of guanine as a site of methylation. , 1970, The Biochemical journal.

[57]  F. Murad,et al.  Requirement for a macromolecular factor for sodium azide activation of guanulate cyclase. , 1975, Journal of cyclic nucleotide research.

[58]  R. Miller,et al.  Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells , 1984, British journal of pharmacology.

[59]  A. Bove,et al.  Increased vasoconstrictor activity of proximal coronary arteries with endothelial damage in intact dogs. , 1984, Circulation.

[60]  M. Lewis,et al.  Endothelium‐derived relaxing factor inhibits in vitro platelet aggregation , 1987, British journal of pharmacology.

[61]  P. Vanhoutte,et al.  The calcium agonists Bay K 8644 and (+)202,791 stimulate the release of endothelial relaxing factor from canine femoral arteries. , 1985, European journal of pharmacology.

[62]  J. Angus,et al.  Vasodilatation by acetylcholine is endothelium‐dependent: a study by sonomicrometry in canine femoral artery in vivo. , 1983, The Journal of physiology.

[63]  R. Andersson,et al.  Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. , 1983, European journal of pharmacology.

[64]  F. Murad,et al.  Regulation of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate levels and contractility in bovine tracheal smooth muscle. , 1977, Molecular pharmacology.

[65]  R. Alexander,et al.  Inhibition of platelet function by organic nitrate vasodilators. , 1980, Blood.

[66]  E. Bassenge,et al.  Two dilatory mechanisms of anti-anginal drugs on epicardial coronary arteries in vivo: indirect, flow-dependent, endothelium-mediated dilation and direct smooth muscle relaxation. , 1983, Zeitschrift fur Kardiologie.

[67]  J. Horowitz,et al.  Prevention and Reversal of Tolerance to Nitroglycerine with N‐Acetylcysteine , 1985, Journal of cardiovascular pharmacology.

[68]  L. Ignarro,et al.  Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. , 1981, The Journal of pharmacology and experimental therapeutics.

[69]  G. H. Nelson,et al.  Laser-induced endothelial damage inhibits endothelium-dependent relaxation in the cerebral microcirculation of the mouse. , 1987, Circulation research.

[70]  J. Povlishock,et al.  Oxygen Radicals Mediate the Cerebral Arteriolar Dilation from Arachidonate and Bradykinin in Cats , 1984, Circulation research.

[71]  R. Keith,et al.  Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. , 1982, The Journal of pharmacology and experimental therapeutics.

[72]  R. Busse,et al.  Characterization of vascular relaxant factor released from cultured endothelial cells. , 1987, Hypertension.

[73]  U. Förstermann,et al.  Selective inhibition by gossypol of endothelium‐dependent relaxations augments relaxations to glyceryl trinitrate in rabbit coeliac artery , 1987, British journal of pharmacology.

[74]  P. Needleman,et al.  Mechanism of tolerance development to organic nitrates. , 1973, The Journal of pharmacology and experimental therapeutics.

[75]  R. Furchgott,et al.  Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. , 1986, The Journal of pharmacology and experimental therapeutics.

[76]  R. Furchgott.  The role of endothelium in the responses of vascular smooth muscle to drugs. , 1984, Annual review of pharmacology and toxicology.

[77]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[78]  R. Bing,et al.  Release of Endothelium‐Derived Relaxing Factor From Freshly Harvested Porcine Endothelial Cells , 1987, Circulation research.

[79]  L. Ignarro,et al.  Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. , 1987, Circulation research.

[80]  J. Diamond,et al.  Relationship between cyclic nucleotide levels and drug-induced relaxation of smooth muscle. , 1979, The Journal of pharmacology and experimental therapeutics.

[81]  B. Altura,et al.  Endothelium‐dependent relaxation in coronary arteries requires magnesium ions , 1987, British journal of pharmacology.

[82]  V. Miller,et al.  Modulation of vascular smooth muscle contraction by the endothelium. , 1986, Annual review of physiology.

[83]  A. Saxon,et al.  Platelet inhibition by sodium nitroprusside, a smooth muscle inhibitor. , 1976, Blood.

[84]  P. Davies,et al.  Haemodynamic shear stress activates a K+ current in vascular endothelial cells , 1988, Nature.

[85]  F. Murad,et al.  Mechanisms of Adenosine Triphosphate‐, Thrombin‐, and Trypsin‐induced Relaxation of Rat Thoracic Aorta , 1984, Circulation research.

[86]  O. V. Miller,et al.  Modulation of human platelet adenylate cyclase by prostacyclin (PGX). , 1977, Prostaglandins.

[87]  L. Ignarro,et al.  Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. , 1981, Canadian journal of physiology and pharmacology.

[88]  S. Moncada.  EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN , 1982, British journal of pharmacology.

[89]  E. Salzman,et al.  Role of cyclic AMP in platelet function. , 1972, Advances in cyclic nucleotide research.

[90]  L. Ignarro,et al.  Evidence that regulation of hepatic guanylate cyclase activity involves interactions between catalytic site -SH groups and both substrate and activator. , 1981, Archives of biochemistry and biophysics.

[91]  J. Ahlner,et al.  Development of tolerance to glyceryl trinitrate in an isolated human peripheral vein and its relation to cyclic GMP metabolism. , 2009, Acta pharmacologica et toxicologica.

[92]  G. Carnahan,et al.  An unusually stable thionitrite from N-acetyl-D,L-penicillamine; X-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite , 1978 .

[93]  R. Paul,et al.  Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. , 1985, The American journal of physiology.

[94]  M. Marletta,et al.  Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[95]  L. Ignarro,et al.  Relaxation of bovine coronary arterial smooth muscle by cyclic GMP, cyclic AMP and analogs. , 1980, The Journal of pharmacology and experimental therapeutics.

[96]  P. Vanhoutte,et al.  Endothelium‐dependent hyperpolarization of canine coronary smooth muscle , 1988, British journal of pharmacology.

[97]  M. Winniford,et al.  Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine. , 1986, Circulation.

[98]  U. Förstermann,et al.  Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition. , 1984, Journal of cardiovascular pharmacology.

[99]  M. Marletta,et al.  Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[100]  R. Schoental,et al.  Interaction of N-alkyl-N-nitrosourethanes with thiols. , 1965, The Biochemical journal.

[101]  L. Ignarro,et al.  Possible involvement of S‐nitrosothiols in the activation of guanylate cyclase by nitroso compounds , 1980, FEBS letters.

[102]  J. Vane,et al.  An Enzyme Isolated from Arteries Transforms Prostaglandin Endoperoxides to an Unstable Substance that Inhibits Platelet Aggregation. , 1977 .

[103]  L. Ignarro,et al.  Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. , 1982, Biochimica et biophysica acta.

[104]  S. Moncada,et al.  Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets , 1987, British journal of pharmacology.

[105]  L. Ignarro,et al.  Methemoglobin blockade of coronary arterial soluble guanylate cyclase activation by nitroso compounds and its reversal with dithiothreitol , 1979, FEBS letters.

[106]  J. Vane,et al.  Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[107]  L. Ignarro,et al.  Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. , 1983, Molecular pharmacology.

[108]  S. Holzmann.  Endothelium-induced relaxation by acetylcholine associated with larger rises in cyclic GMP in coronary arterial strips. , 1982, Journal of cyclic nucleotide research.

[109]  R. Busse,et al.  Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor. , 1986, The Journal of pharmacology and experimental therapeutics.

[110]  L. Ignarro,et al.  Activation of purified soluble guanylate cyclase by protoporphyrin IX. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[111]  R Busse,et al.  Crucial role of endothelium in the vasodilator response to increased flow in vivo. , 1986, Hypertension.

[112]  M. Marcus,et al.  Removal of the Endothelium Potentiates Canine Large Coronary Artery Constrictor Responses to 5‐Hydroxytryptamine in Vivo , 1985, Circulation research.

[113]  R. Haslam,et al.  Factors affecting platelet cyclic GMP levels during aggregation induced by collagen and by arachidonic acid. , 1976, Thrombosis research.

[114]  F. Murad,et al.  Properties and regulation of guanylate cyclase and some proposed functions for cyclic GMP. , 1979, Advances in cyclic nucleotide research.

[115]  U. Förstermann,et al.  Endothelium-dependent relaxation of human epicardial coronary arteries: frequent lack of effect of acetylcholine. , 1986, European journal of pharmacology.

[116]  R. Busse,et al.  Selective inhibition of endothelium-dependent dilation in resistance-sized vessels in vivo. , 1987, The American journal of physiology.

[117]  P. Ramwell,et al.  Endothelium dependent vascular relaxation by arginine containing polypeptides. , 1986, Biochemical and biophysical research communications.

[118]  R. Winquist,et al.  Blockade of endothelium-dependent relaxation by the amiloride analog dichlorobenzamil: possible role of Na+/Ca++ exchange in the release of endothelium-derived relaxant factor. , 1985, The Journal of pharmacology and experimental therapeutics.

[119]  L. Ignarro,et al.  Activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside, and nitrosoguanidine--inhibition by calcium, lanthanum, and other cations, enhancement by thiols. , 1980, Biochemical pharmacology.

[120]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[121]  L. Ignarro,et al.  Atriopeptin II relaxes and elevates cGMP in bovine pulmonary artery but not vein. , 1986, Journal of applied physiology.

[122]  J. White,et al.  The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation. , 1977, Journal of cyclic nucleotide research.

[123]  L. Ignarro,et al.  EDRF generation and release from perfused bovine pulmonary artery and vein. , 1988, European journal of pharmacology.

[124]  P. Vanhoutte,et al.  Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. , 1986, The American journal of physiology.

[125]  P. Vanhoutte,et al.  Heterogeneous Behavior of the Canine Arterial and Venous Wall: Importance of the Endothelium , 1982, Circulation research.

[126]  M. Claeys,et al.  Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. , 1982, The Journal of pharmacology and experimental therapeutics.

[127]  L. Ignarro,et al.  Selective alterations in responsiveness of guanylate cyclase to activation by nitroso compounds during enzyme purification. , 1981, Biochimica et biophysica acta.

[128]  S. S. Hull,et al.  Methylene blue and ETYA block flow-dependent dilation in canine femoral artery. , 1986, The American journal of physiology.

[129]  B. Berkowitz,et al.  Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle. , 1987, The Journal of pharmacology and experimental therapeutics.

[130]  L. Ignarro,et al.  Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate. , 1985, The Journal of pharmacology and experimental therapeutics.

[131]  R. Johns,et al.  Para-bromophenacyl bromide inhibits endothelium-dependent arterial relaxation and cyclic GMP accumulation by effects produced exclusively in the smooth muscle. , 1988, The Journal of pharmacology and experimental therapeutics.

[132]  G. Schultz,et al.  Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets. , 1978, Advances in cyclic nucleotide research.

[133]  R. Busse,et al.  Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor from cultured endothelial cells. , 1987, European journal of pharmacology.

[134]  J. Diamond,et al.  Effects of stimulant and relaxant drugs on tension and cyclic nucleotide levels in canine femoral artery. , 1976, Molecular pharmacology.

[135]  L. Ignarro,et al.  Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. , 1981, Blood.

[136]  R. Furchgott,et al.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. , 1985, The Journal of pharmacology and experimental therapeutics.

[137]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[138]  M. Peach,et al.  Role of calcium in endothelium-dependent relaxation of arterial smooth muscle. , 1987, The American journal of cardiology.

[139]  B. Levine,et al.  In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries. , 1987, The New England journal of medicine.

[140]  J. Diamond,et al.  Effects of potassium chloride and smooth muscle relaxants on tension and cyclic nucleotide levels in rat myometrium. , 1975, Canadian journal of physiology and pharmacology.

[141]  S. Moncada,et al.  The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide , 1987, British journal of pharmacology.

[142]  G. Schultz,et al.  Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens , 1977, Nature.

[143]  G. H. Nelson,et al.  In Vivo Effect of Methylene Blue on Endothelium‐Dependent and Endothelium‐Independent Dilations of Brain Microvessels in Mice , 1988, Circulation research.

[144]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[145]  B. Altura,et al.  Influence of magnesium on drug-induced contractions and ion content in rabbit aorta. , 1971, The American journal of physiology.

[146]  J. C. Woolum,et al.  Isolation and identification of a paramagnetic complex from the livers of carcinogen-treated rats. , 1970, Biochimica et biophysica acta.

[147]  S. Moncada,et al.  Mechanism of action of some inhibitors of endothelium-derived relaxing factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[148]  L. Ignarro,et al.  Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. , 1988, The Journal of pharmacology and experimental therapeutics.

[149]  H. Ensley,et al.  Inhibition of soybean lipoxygenase by SKF 525-A and metyrapone. , 1985, Prostaglandins.

[150]  L. Ignarro,et al.  Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms. , 1986, The Journal of biological chemistry.

[151]  A. Saxon,et al.  Platelet inhibiton by sodium nitroprusside, a smooth muscle inhibitor , 1976 .

[152]  S. Tannenbaum,et al.  Nitrosation of amines by stimulated macrophages. , 1987, Carcinogenesis.

[153]  L. Ignarro,et al.  The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. , 1985, Annual review of pharmacology and toxicology.

[154]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[155]  J. Hibbs,et al.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. , 1987, Science.

[156]  A. Kang,et al.  Effect of cyclic 3',5'-guanosine monophosphate on human platelet function. , 1976, The Journal of laboratory and clinical medicine.

[157]  L. Ignarro,et al.  Guanylate cyclase from bovine lung. A kinetic analysis of the regulation of the purified soluble enzyme by protoporphyrin IX, heme, and nitrosyl-heme. , 1982, The Journal of biological chemistry.

[158]  F. Murad,et al.  Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. , 1977, Journal of cyclic nucleotide research.

[159]  L. Ignarro,et al.  Guanylate cyclase activation of nitroprusside and nitrosoguanidine is related to formation of S-nitrosothiol intermediates. , 1980, Biochemical and biophysical research communications.

[160]  L. Ignarro,et al.  Basic Polyamino Acids Rich in Arginine, Lysine, or Ornithine Cause Both Enhancement of and Refractoriness to Formation of Endothelium‐Derived Nitric Oxide in Pulmonary Artery and Vein , 1989, Circulation research.

[161]  C. Higgins,et al.  Provocation of coronary spasm with ergonovine maleate. New test with results in 57 patients undergoing coronary arteriography. , 1977, The American journal of cardiology.

[162]  A. Herman,et al.  Effect of Hypercholesterolemia on Vascular Reactivity in the Rabbit: I. Endothelium‐Dependent and Endothelium‐Independent Contractions and Relaxations in Isolated Arteries of Control and Hypercholesterolemic Rabbits , 1986, Circulation research.

[163]  B. Berkowitz,et al.  Anion exchange resins discriminate between nitric oxide and EDRF. , 1987, European journal of pharmacology.

[164]  T. Rimele,et al.  Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. , 1988, The Journal of pharmacology and experimental therapeutics.

[165]  U. Förstermann,et al.  Selective Attenuation of Endothelium‐Mediated Vasodilation in Atherosclerotic Human Coronary Arteries , 1988, Circulation research.

[166]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[167]  R. Furchgott,et al.  Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor. , 1986, The Journal of pharmacology and experimental therapeutics.

[168]  S. Moncada,et al.  Bioassay of prostacyclin and endothelium‐derived relaxing factor (EDRF) from porcine aortic endothelial cells , 1997, British journal of pharmacology.

[169]  F. Murad,et al.  Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. , 1978, Advances in cyclic nucleotide research.

[170]  M. Peach,et al.  Endothelium-dependent relaxation of rabbit aorta. I. Relaxation stimulated by arachidonic acid. , 1983, The Journal of pharmacology and experimental therapeutics.

[171]  M. Ishikawa,et al.  Endothelium‐dependent inhibition of platelet aggregation , 1986, British journal of pharmacology.

[172]  谷島 健生.  Cerebral vasospasm : contractile activity of hemoglobin in isolated canine basilar arteries , 1981 .

[173]  M. Lewis,et al.  Evidence that cyclic guanosine monophosphate (cGMP) mediates endothelium-dependent relaxation. , 1985, European journal of pharmacology.

[174]  K. Macleod,et al.  Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation. , 1987, Molecular pharmacology.

[175]  P. Needleman,et al.  Sulfhydryl requirement for relaxation of vascular smooth muscle. , 1973, The Journal of pharmacology and experimental therapeutics.

[176]  R. Furchgott,et al.  Role of endothelial cells in relaxation of isolated arteries by bradykinin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[177]  L. Ignarro,et al.  Purification and properties of heme-deficient hepatic soluble guanylate cyclase: effects of heme and other factors on enzyme activation by NO, NO-heme, and protoporphyrin IX. , 1982, Archives of biochemistry and biophysics.

[178]  J. Povlishock,et al.  Appearance of Superoxide Anion Radical in Cerebral Extracellular Space during Increased Prostaglandin Synthesis in Cats , 1985, Circulation research.

[179]  M. Feelisch,et al.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. , 1987, European journal of pharmacology.

[180]  L. Ignarro,et al.  Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N'-nitrosonornicotine and nitric oxide. , 1980, The Journal of pharmacology and experimental therapeutics.

[181]  F. DeRubertis,et al.  Electron spin resonance study of the role of NO . catalase in the activation of guanylate cyclase by NaN3 and NH2OH. Modulation of enzyme responses by heme proteins and their nitrosyl derivatives. , 1979, The Journal of biological chemistry.

[182]  B. Altura.  Sudden-death ischemic heart disease and dietary magnesium intake: is the target site coronary vascular smooth muscle? , 1979, Medical hypotheses.

[183]  U. Förstermann,et al.  Endothelium-derived relaxing factor is likely to modulate the tone of resistance arteries in rabbit hindlimb in vivo. , 1987, The Journal of pharmacology and experimental therapeutics.

[184]  L. Ignarro,et al.  Activation of purified soluble guanylate cyclase by arachidonic acid requires absence of enzyme-bound heme. , 1987, Biochimica et biophysica acta.

[185]  J. Angus,et al.  Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin , 1983, Nature.

[186]  L. Ignarro,et al.  Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. , 1984, The Journal of biological chemistry.

[187]  B. Saville.  A scheme for the colorimetric determination of microgram amounts of thiols , 1958 .

[188]  J. Linden,et al.  Modulation of guanylate cyclase by lipoxygenase inhibitors. , 1986, Hypertension.

[189]  U. Förstermann,et al.  Endothelium-dependent vasodilation by melittin: are lipoxygenase products involved? , 1985, The American journal of physiology.

[190]  J. Atkinson,et al.  Platelet release reaction and intracellular cGMP. , 1978, Blood.

[191]  M. Lewis,et al.  Isolated perfused rabbit coronary artery and aortic strip preparations: the role of endothelium‐derived relaxant factor. , 1984, The Journal of physiology.

[192]  J. Diamond,et al.  Increases in cyclic GMP levels may not mediate relaxant effects of sodium nitroprusside, verapamil and hydralazine in rat vas deferens , 1978, Nature.

[193]  L. Ignarro,et al.  Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. , 1987, The American journal of physiology.

[194]  R. Estabrook,et al.  Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[195]  M. Kodama,et al.  FREE RADICAL INDUCED IN RAT LIVER BY A CHEMICAL CARCINOGEN, N‐METHYL‐N′‐NITRO‐N‐NITROSOGUANIDINE * , 1973, Annals of the New York Academy of Sciences.

[196]  J. Fox,et al.  Cyclic Nucleotides in Platelet Function , 1977, Thrombosis and Haemostasis.

[197]  D. R. McCalla,et al.  Inactivation of biologically active N-methyl-N-nitroso compounds in aqueous solution: effect of various conditions of pH and illumination. , 1968, Canadian journal of biochemistry.

[198]  K. Tanaka,et al.  Coronary artery spasm induced in atherosclerotic miniature swine. , 1983, Science.

[199]  K. Jakobs,et al.  Proceedings: Cyclic GMP formation in human platelets. , 1974, Naunyn-Schmiedeberg's archives of pharmacology.

[200]  Julie H. Campbell,et al.  Release and properties of endothelium‐derived relaxing factor (EDRF) from endothelial cells in culture , 1985, Journal of cellular physiology.

[201]  S. Marklund,et al.  Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. , 1974, European journal of biochemistry.

[202]  U. Förstermann,et al.  Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. , 1987, Thrombosis research.

[203]  S. S. Hull,et al.  Endothelium-dependent flow-induced dilation of canine femoral and saphenous arteries. , 1986, Blood vessels.

[204]  L. Ignarro,et al.  Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols. , 1980, Biochimica et biophysica acta.

[205]  G. Schultz,et al.  Purification of a soluble, sodium-nitroprusside-stimulated guanylate cyclase from bovine lung. , 1981, European journal of biochemistry.

[206]  L. Ignarro,et al.  Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. , 1986, The Journal of pharmacology and experimental therapeutics.

[207]  H. Schmidt,et al.  Arginine is a physiological precursor of endothelium-derived nitric oxide. , 1988, European journal of pharmacology.

[208]  E. Ohlstein,et al.  Differential selectivity of endothelium‐derived relaxing factor and nitric oxide in smooth muscle , 1987, British journal of pharmacology.

[209]  T. Martin,et al.  Calcitonin gene-related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells. , 1985, Biochemical and biophysical research communications.

[210]  D. Stewart,et al.  Long-term nitroglycerin treatment: effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs. , 1987, Circulation.

[211]  J. Diamond,et al.  Possible role for cyclic GMP in endothelium-dependent relaxation of rabbit aorta by acetylcholine. Comparison with nitroglycerin. , 1983, Research communications in chemical pathology and pharmacology.

[212]  M. Wolin,et al.  Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. , 1987, The American journal of physiology.

[213]  F. Murad,et al.  Agonist‐Induced Endothelium‐Dependent Relaxation in Rat Thoracic Aorta May Be Mediated through cGMP , 1983, Circulation research.

[214]  B. Altura,et al.  Acetylcholine and bradykinin relax intrapulmonary arteries by acting on endothelial cells: role in lung vascular diseases. , 1981, Science.

[215]  L. Ignarro,et al.  Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. , 1981, The Journal of pharmacology and experimental therapeutics.

[216]  E. Antman,et al.  Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. , 1983, Circulation.

[217]  R. Miller,et al.  Insensitivity of calcium‐dependent endothelial stimulation in rat isolated aorta to the calcium entry blocker, flunarizine , 1985, British journal of pharmacology.

[218]  J. Vane,et al.  Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. , 1977, Prostaglandins.

[219]  L. Ignarro,et al.  Endothelium-derived nitric oxide relaxes nonvascular smooth muscle. , 1989, European journal of pharmacology.

[220]  P. Vanhoutte.  Endothelium-dependent contractions in arteries and veins. , 1987, Blood vessels.

[221]  H. Morris,et al.  Calcitonin gene-related peptide is a potent vasodilator , 1985, Nature.

[222]  J. Bevan,et al.  Flow-dependent dilation in myograph-mounted resistance artery segments. , 1988, Blood vessels.

[223]  R. Furchgott.  Role of endothelium in responses of vascular smooth muscle. , 1983, Circulation research.

[224]  U. Förstermann.  Properties and mechanisms of production and action of endothelium-derived relaxing factor. , 1986, Journal of cardiovascular pharmacology.

[225]  F. DeRubertis,et al.  Calcium-independent modulation of cyclic GMP and activation of guanylate cyclase by nitrosamines. , 1976, Science.

[226]  B. Altura,et al.  Magnesium and vascular tone and reactivity. , 1978, Blood vessels.

[227]  L. Ignarro,et al.  Regulation of purified soluble guanylate cyclase by porphyrins and metalloporphyrins: a unifying concept. , 1984, Advances in cyclic nucleotide and protein phosphorylation research.

[228]  R. Gerzer,et al.  The separation of the heme and apoheme forms of soluble guanylate cyclase. , 1982, Biochemical and biophysical research communications.

[229]  L. Ignarro,et al.  Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. , 1984, The Journal of pharmacology and experimental therapeutics.

[230]  H. Hidaka,et al.  Stimulation of human platelet guanylate cyclase by unsaturated fatty acid peroxides. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[231]  J. Hibbs,et al.  L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. , 1987, Journal of immunology.

[232]  J. Brien,et al.  Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta. , 1986, The Journal of pharmacology and experimental therapeutics.